You are not logged in. Press here to login.

Content

List volumes - List articles in this issue

OPTIMAL STIMULATION DURATION OF TENS IN THE MANAGEMENT OF OSTEOARTHRITIC KNEE PAIN

doi: 10.1080/16501970306116

Open access

Abstract:

OBJECTIVE: This study examined the optimal stimulation duration of transcutaneous electrical nerve stimulation (TENS) for relieving osteoarthritic knee pain and the duration (as measured by half-life) of post-stimulation analgesia. SUBJECTS: Thirty-eight patients received either: (i) 20 minutes (TENS20); (ii) 40 minutes (TENS40); (iii) 60 minutes (TENS60) of TENS; or (iv) 60 minutes of placebo TENS (TENSPL) 5 days a week for 2 weeks. METHODS: A visual analogue scale recorded the magnitude and pain relief period for up to 10 hours after stimulation. RESULTS: By Day10, a significantly greater cumulative reduction in the visual analogue scale scores was found in the TENS40 (83.40%) and TENS60 (68.37%) groups than in the TENS20 (54.59%) and TENSPL (6.14%) groups (p 3 0.000), such a group difference was maintained in the 2-week followup session (p 3 0.000). In terms of the duration of post-stimulation analgesia period, the duration for the TENS40 (256 minutes) and TENS60 (258 minutes) groups was more prolonged than in the other 2 groups (TENS20 = 168 minutes, TENSPL = 35 minutes) by Day10 (p 3 0.000). However, the TENS40 group produced the longest pain relief period by the follow-up session. CONCLUSION: 40 minutes is the optimal treatment duration of TENS, in terms of both the magnitude (VAS scores) of pain reduction and the duration of post-stimulation analgesia for knee osetoarthritis.

Authors:

Gladys L. Y. Cheing A1, Amy Y. Y. Tsui A1, Sing Kai Lo A1, Christina W. Y. Hui-Chan A1
A1 Department of Rehabilitation Sciences, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong



Related articles

There are no related articles.


Actions


Abstract

PDF

Supplementary


There is no supplementary for this article.

Related articles


Click here to show related articles

Print information


Volume 35, Issue 2

DOI: 10.1080/16501970306116

Pages: 62-68

View at PubMed